| Methods |
Double‐blind, randomised, placebo‐controlled trial |
| Participants |
40 participants
Eligibility criteria: presence and duration of sore throat, odynophagia, respiratory distress, fatigue and fever. A bacterial throat culture, monotest and Epstein‐Barr virus were performed to reach final diagnosis of infectious mononucleosis‐induced acute sore throat |
| Interventions |
Intervention: one dose of dexamethasone oral 0.3 mg/kg
Control: placebo |
| Outcomes |
Duration of sore throat, fever and rate of return to social activities |
| Notes |
— |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Low risk |
Computer‐generated |
| Allocation concealment (selection bias) |
Low risk |
Allocation sequence held remotely |
| Blinding (performance bias and detection bias)
All outcomes |
Low risk |
All personnel and participants blinded |
| Incomplete outcome data (attrition bias)
All outcomes |
Low risk |
— |
| Selective reporting (reporting bias) |
Unclear risk |
— |
| Other bias |
Unclear risk |
— |
